Medtronic Maxon 75 cm Straight Size 4-0 SC-2 Monofilament Polyglyconate Synthetic Absorbable Suture, Clear, 36/Box
This product is also in these categories:
Product Information:
- Products Model: 8886690831
- Product Brand: Medtronic
- Condition: New
- This special-order item ships in an estimated 4-6 weeks.
- Warranty: Satisfaction Guaranteed
Maxon monofilament polyglyconate synthetic absorbable suture is prepared from a copolymer of glycolic acid and trimethylene carbonate. Maxon suture is indicated for use as absorbable suture in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular tissue. Maxon suture is not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissue. Maxon synthetic absorbable suture elicit a minimal acute inflammatory reaction in tissues, which is followed by gradual encapsulation of the suture by fibrous connective tissue. Progressive loss of tensile strength and eventual absorption of maxon synthetic absorbable suture occurs by means of hydrolysis where the suture is broken down and subsequently absorbed and metabolized by the body. Studies indicate that tensile strength for maxon suture is approximately 80% of the original suture strength at one week post-implant. Approximately 75% of the original suture strength remains at two weeks, 65% at three weeks, 50% at four weeks and 25% at six weeks post-implant. Absorption of maxon synthetic absorbable suture is minimal until about the 60th day after implantation and is essentially complete within six months.
Features
- Excellent in-vivo strength retention
- Excellent knot tying security
- Excellent handling
- Minimal memory
Specification
- Application: Suture
- Material: Monofilament Polyglyconate
- Absorption: Absorbable
- Sterilization: Ethylene Oxide
- Needle Name: SC-2
- Needle Length: 60 mm
- Needle Type: Conventional Cutting
- Curvature: Straight
- Arms: Single
- Length: 75 cm
- Sterility: Sterile
- Size USP: 4-0
- Metric Value: 1.5
- Color: Clear
- Package Quantity: 36 per Box
Maxon monofilament polyglyconate synthetic absorbable suture is prepared from a copolymer of glycolic acid and trimethylene carbonate. Maxon suture is indicated for use as absorbable suture in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular tissue. Maxon suture is not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissue. Maxon synthetic absorbable suture elicit a minimal acute inflammatory reaction in tissues, which is followed by gradual encapsulation of the suture by fibrous connective tissue. Progressive loss of tensile strength and eventual absorption of maxon synthetic absorbable suture occurs by means of hydrolysis where the suture is broken down and subsequently absorbed and metabolized by the body. Studies indicate that tensile strength for maxon suture is approximately 80% of the original suture strength at one week post-implant. Approximately 75% of the original suture strength remains at two weeks, 65% at three weeks, 50% at four weeks and 25% at six weeks post-implant. Absorption of maxon synthetic absorbable suture is minimal until about the 60th day after implantation and is essentially complete within six months.
Features
- Excellent in-vivo strength retention
- Excellent knot tying security
- Excellent handling
- Minimal memory
Specification
- Application: Suture
- Material: Monofilament Polyglyconate
- Absorption: Absorbable
- Sterilization: Ethylene Oxide
- Needle Name: SC-2
- Needle Length: 60 mm
- Needle Type: Conventional Cutting
- Curvature: Straight
- Arms: Single
- Length: 75 cm
- Sterility: Sterile
- Size USP: 4-0
- Metric Value: 1.5
- Color: Clear
- Package Quantity: 36 per Box
Maxon monofilament polyglyconate synthetic absorbable suture is prepared from a copolymer of glycolic acid and trimethylene carbonate. Maxon suture is indicated for use as absorbable suture in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular tissue. Maxon suture is not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissue. Maxon synthetic absorbable suture elicit a minimal acute inflammatory reaction in tissues, which is followed by gradual encapsulation of the suture by fibrous connective tissue. Progressive loss of tensile strength and eventual absorption of maxon synthetic absorbable suture occurs by means of hydrolysis where the suture is broken down and subsequently absorbed and metabolized by the body. Studies indicate that tensile strength for maxon suture is approximately 80% of the original suture strength at one week post-implant. Approximately 75% of the original suture strength remains at two weeks, 65% at three weeks, 50% at four weeks and 25% at six weeks post-implant. Absorption of maxon synthetic absorbable suture is minimal until about the 60th day after implantation and is essentially complete within six months.
Features
- Excellent in-vivo strength retention
- Excellent knot tying security
- Excellent handling
- Minimal memory
Specification
- Application: Suture
- Material: Monofilament Polyglyconate
- Absorption: Absorbable
- Sterilization: Ethylene Oxide
- Needle Name: SC-2
- Needle Length: 60 mm
- Needle Type: Conventional Cutting
- Curvature: Straight
- Arms: Single
- Length: 75 cm
- Sterility: Sterile
- Size USP: 4-0
- Metric Value: 1.5
- Color: Clear
- Package Quantity: 36 per Box